- Investor's Business Daily•7 hours ago
Roche, Merck and Pfizer will likely disappoint on 2017 guidance, but AbbVie stock remains a "top pick" for Jefferies analyst Jeffrey Holford.
- Zacks•8 hours ago
Swiss pharmaceutical company Novartis AG (NVS) is scheduled to report fourth-quarter and full year 2016 results on Jan 25.
- Zacks•9 hours ago
Market sentiment seems to be improving courtesy of raised outlooks, new product approvals and encouraging pipeline updates.
ABBV: Summary for AbbVie Inc. Common Stock - Yahoo Finance
AbbVie Inc. (ABBV)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
|Day's range||61.08 - 61.77|
|52-week range||51.60 - 68.12|
Trade prices are not sourced from all markets
|PE ratio (TTM)||16.53|
|Dividend & yield||2.56 (4.15%)|
|1y target est||N/A|